Lipoprotein glomerulopathy


Proteinuria

Increased levels of protein in the urine.


Total: 7

                       


(per page)
PMID (PMCID)
24348079
(3859823)
 OTHER
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e.
Magistroni R, Bertolotti M, Furci L, Fano RA, Leonelli M, Pisciotta L, Pellegrini E, Calabresi L, Bertolini S, Calandra S.
Clin Med Insights Case Rep. 2013;6:189-96.
We describe a 51-year-old Italian patient presenting Type III hyperlipidemia and proteinuria in whom renal biopsy showed capillary ectasia and intraluminal lipid deposits, suggesting the diagnosis of lipoprotein glomerulopathy.
20121619
 MALE Adult
A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
Boumendjel R, Papari M, Gonzalez M.
Arch Pathol Lab Med. 2010;134(2):279-82.
Lipoprotein glomerulopathy is clinically characterized by proteinuria and progression to renal failure and is caused by glomerular lipoprotein thrombi formation in association with increased levels of serum apolipoprotein E. The disease has a male predominance and can affect virtually any age group.
20062740
(2803834)
 OTHER
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.
Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, Albertazzi A.
J Med Case Rep. 2009;3:9311.
According to this case of lipoprotein glomerulopathy, we believe that renal damage expressed by proteinuria correlates to the levels of lipids and, furthermore, the treatment with HELP-apheresis, by lowering low-density lipoprotein cholesterol and triglycerides, may be considered as a therapeutic option in synergy with pharmacological treatment in the treatment of lipoprotein glomerulopathy.
20062740
(2803834)
 OTHER
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.
Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P, Albertazzi A.
J Med Case Rep. 2009;3:9311.
According to this case of lipoprotein glomerulopathy, we believe that renal damage expressed by proteinuria correlates to the levels of lipids and, furthermore, the treatment with HELP-apheresis, by lowering low-density lipoprotein cholesterol and triglycerides, may be considered as a therapeutic option in synergy with pharmacological treatment in the treatment of lipoprotein glomerulopathy.
11877595
 FEMALE Middle Aged
A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
Hayakawa M, Okubo M, Katori H, Nagahama K, Murase T, Kobayashi T, Tanaka S, Nakanishi K, Odawara M, Matsushita H, Yamada A.
Am J Kidney Dis. 2002;39(3):E15.
Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.
11833049
 MALE Adult
Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg-->Cys) from a patient with lipoprotein glomerulopathy.
Murano T, Matsumura R, Misawa Y, Ozaki H, Miyashita Y, Yoshida S, Sueioshi M, Sugiyama T, Shirai K.
Metabolism. 2002;51(2):201-5.
We saw a patient with proteinuria and characteristics of lipoprotein glomerulopathy (LPG).
10405216
 MALE Adult
Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney.
Miyata T, Sugiyama S, Nangaku M, Suzuki D, Uragami K, Inagi R, Sakai H, Kurokawa K.
J Am Soc Nephrol. 1999;10(7):1590-5.
Lipid abnormalities are associated with various disorders ranging from generalized atherosclerosis to renal diseases, including lipoprotein glomerulopathy that is characterized by glomerular lipoprotein thrombi and causes type III hyperlipoproteinemia, proteinuria, and renal failure.